LINDSEY BLANTON: Open Payments
NPI 1154046811 · CONNERSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 69 payments from 15 companies in 2025. Trend: 2023 $397 · 2024 $624 · 2025 $1,205
Food & beverage: $1,110Education: $95
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $283 |
| Otsuka America Pharmaceutical, Inc. | 12 | $236 |
| ABBVIE INC. | 13 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $141 |
| PFIZER INC. | 3 | $79 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Indivior Inc. | 4 | $60 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: FANAPT, REXULTI, CAPLYTA, NURTEC ODT, MAVYRET, INGREZZA, VRAYLAR, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
